NO20002013D0 - Suspension packaging cell lines for retroviral vectors - Google Patents

Suspension packaging cell lines for retroviral vectors

Info

Publication number
NO20002013D0
NO20002013D0 NO20002013A NO20002013A NO20002013D0 NO 20002013 D0 NO20002013 D0 NO 20002013D0 NO 20002013 A NO20002013 A NO 20002013A NO 20002013 A NO20002013 A NO 20002013A NO 20002013 D0 NO20002013 D0 NO 20002013D0
Authority
NO
Norway
Prior art keywords
cell lines
retroviral vectors
packaging cell
suspension
suspension packaging
Prior art date
Application number
NO20002013A
Other languages
Norwegian (no)
Other versions
NO20002013L (en
Inventor
Stefan Seeber
Stefan Koch
Thorsten Gutjahr
Ulrich Steegmans
Ruediger Rueger
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Publication of NO20002013L publication Critical patent/NO20002013L/en
Publication of NO20002013D0 publication Critical patent/NO20002013D0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0693—Tumour cells; Cancer cells
    • C12N5/0694—Cells of blood, e.g. leukemia cells, myeloma cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13051—Methods of production or purification of viral material
    • C12N2740/13052—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The invention relates to a packing cell line fully growing in a suspension, which is transfected with a retrovirus plasmid or transduced with a retrovirus vector. The invention aslo relates to a method for the production of said cell lines from suspension cell lines or adheringly growing cell lines.
NO20002013A 1997-10-25 2000-04-17 Suspension packaging cell lines for retroviral vectors NO20002013D0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP97118583 1997-10-25
EP97121724 1997-12-10
PCT/EP1998/006714 WO1999021967A1 (en) 1997-10-25 1998-10-22 Suspension packing cell lines for retrovirus vectors

Publications (2)

Publication Number Publication Date
NO20002013L NO20002013L (en) 2000-04-17
NO20002013D0 true NO20002013D0 (en) 2000-04-17

Family

ID=26145852

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20002013A NO20002013D0 (en) 1997-10-25 2000-04-17 Suspension packaging cell lines for retroviral vectors

Country Status (16)

Country Link
EP (1) EP1025207B1 (en)
JP (1) JP3517399B2 (en)
KR (1) KR100359542B1 (en)
CN (1) CN1277631A (en)
AT (1) ATE304048T1 (en)
AU (1) AU729986B2 (en)
BR (1) BR9812960A (en)
CA (1) CA2306634C (en)
DE (1) DE59813048D1 (en)
ES (1) ES2248920T3 (en)
HU (1) HUP0004240A2 (en)
IL (1) IL135541A (en)
NO (1) NO20002013D0 (en)
NZ (1) NZ503827A (en)
TR (1) TR200001125T2 (en)
WO (1) WO1999021967A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100507794B1 (en) * 2003-02-11 2005-08-17 한미약품 주식회사 Method for preparing concentrated retroviral particle dispersion
EP1739180A1 (en) * 2005-06-27 2007-01-03 Max-Delbrück-Centrum für Molekulare Medizin (MDC) T cell line-based packaging cell line for the production of retroviruses by enriching of CD3 expressing cells
JP5923037B2 (en) * 2009-06-17 2016-05-24 トカジェン インコーポレーテッド Production cell of replicable retroviral vector
CN111286517A (en) * 2018-12-07 2020-06-16 珠海联邦制药股份有限公司 A kind of packaging method of replication-defective retrovirus and its application

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4059485A (en) * 1976-11-03 1977-11-22 Monsanto Company Adaptation of cell lines to suspension culture
RU1347448C (en) * 1985-09-27 1995-04-10 Институт полиомиелита и вирусных энцефалитов Российской АМН Strain taurus-1 of heteroploid cells of calf kidney used for virus cultivation
JPH03505675A (en) * 1988-10-31 1991-12-12 ザ リージェンツ オブ ザ ユニヴァーシティ オブ カリフォルニア Producers and methods for controlling suppression of neoplastic phenotypes
DE19612966B4 (en) 1996-04-01 2009-12-10 Novartis Vaccines And Diagnostics Gmbh & Co. Kg MDCK cells and methods of propagating influenza viruses

Also Published As

Publication number Publication date
EP1025207A1 (en) 2000-08-09
NO20002013L (en) 2000-04-17
DE59813048D1 (en) 2005-10-13
TR200001125T2 (en) 2000-09-21
KR20010031387A (en) 2001-04-16
CN1277631A (en) 2000-12-20
JP2001520879A (en) 2001-11-06
AU729986B2 (en) 2001-02-22
IL135541A (en) 2004-02-19
HUP0004240A2 (en) 2001-03-28
KR100359542B1 (en) 2002-10-31
BR9812960A (en) 2000-08-08
WO1999021967A1 (en) 1999-05-06
EP1025207B1 (en) 2005-09-07
JP3517399B2 (en) 2004-04-12
IL135541A0 (en) 2001-05-20
CA2306634C (en) 2005-04-12
ES2248920T3 (en) 2006-03-16
AU1231399A (en) 1999-05-17
ATE304048T1 (en) 2005-09-15
CA2306634A1 (en) 1999-05-06
NZ503827A (en) 2001-06-29

Similar Documents

Publication Publication Date Title
AU2998597A (en) Crossless retroviral vectors
EP1285967A3 (en) Human retroviral packaging cell line
WO1999004026A3 (en) Lentiviral vectors
WO1997007225A3 (en) High efficiency retroviral packaging system
CO4230241A1 (en) BICYCLE COMPOUNDS USEFUL AS GLYCOPROTEIN IIb / IIIa ANTAGONISTS
MY125594A (en) Immortalized cell lines for virus growth
WO1989007136A3 (en) Modified hepatocytes and uses therefor
BR0011489A (en) Film-forming compositions comprising modified starch and iota-carrageenan and processes for making soft capsules using them
MY108663A (en) Liquid detergent compositions containing a suspended peroxygen bleach
ES2128457T5 (en) METALOCENOS WITH SILILO BRIDGE AND ITS USE.
PL345561A1 (en) Substituted benzoylcyclohexandiones
DK0700380T3 (en) N-Alkylthiopolyamine derivatives as radioprotective agents
NO20002013D0 (en) Suspension packaging cell lines for retroviral vectors
WO2000040741A3 (en) Lentivirus vector system
BG108682A (en) Method for the production of transparent flexible container, and container produced therewith
DK0801575T3 (en) Retroviral vectors for expression in embryonic cells
AU6139699A (en) Packaging cell lines for hiv-derived retroviral vector particles
DE69414109D1 (en) PROSTAGLANDIN RECEPTOR EP3 AND ENCODING DNA
DK1097233T3 (en) Promoter for growth differentiation factor and applications thereof
AU5274696A (en) Pseudotyped retroviral particles
DE69716581D1 (en) RETROVIRAL VECTOR AND THEIR USE IN GENTHERAPY
ES2131036A1 (en) Colour-photographic recording material
TNSN89009A1 (en) USE OF ANGIOTENSIN CONVERSION ENZYME INHIBITORS
AR020076A1 (en) ANPHOTROPIC RETROVIRUS PACKAGING CELL LINE, PROCESS FOR ITS PRODUCTION, AND PROCESS FOR THE PRODUCTION OF A RETROVIRAL VECTOR THROUGH THE SAME.
ATE264394T1 (en) CLONING OF UDP-GALACTOSE EPIMERASE

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application